UK markets close in 8 hours 1 minute

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
111.90+0.42 (+0.38%)
At close: 04:03PM EDT
111.95 +0.05 (+0.04%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close111.48
Bid0.00 x 1200
Ask0.00 x 1100
Day's range111.02 - 112.31
52-week range101.24 - 142.60
Avg. volume4,843,114
Market cap195.962B
Beta (5Y monthly)0.70
PE ratio (TTM)23.36
EPS (TTM)4.79
Earnings date18 Oct 2022 - 24 Oct 2022
Forward dividend & yield1.88 (1.68%)
Ex-dividend date14 Jul 2022
1y target est127.91
  • Zacks

    Thermo Fisher (TMO) Debuts Assay for Research on HIV Strains

    Thermo Fisher's (TMO) novel Applied Biosystems HIV-1 Genotyping Kit will aid in the global efforts to monitor the evolution of HIV.

  • Motley Fool

    Should Dividend Investors Add This Stock to Their Portfolios?

    With 50 consecutive years of dividend growth, healthcare giant Abbott Laboratories (NYSE: ABT) is a Dividend King. In late July, Abbott Laboratories shared its financial results for the second quarter ended June 30. As was also the case in the previous quarter, Abbott's nutrition segment was the only segment to not log year-over-year sales growth.

  • Reuters

    Abbott to add 1,000 jobs in $450 million Irish investment

    U.S. healthcare company Abbott Laboratories plans to hire 1,000 more people in Ireland in one of the biggest job announcements this year in the country's booming multinational sector, state investment agency IDA Ireland said on Friday. Abbott, which is one of the largest multinational employers in Ireland with 5,000 staff, will expand its manufacturing facilities in the north west county of Donegal and build a new plant at the other end of the country in Kilkenny. Confirming the $450 million investment, Abbott's senior vice-president for diabetes care, Jared Watkin, told the Irish Times that choosing Ireland for its increased production of devices that monitor glucose levels made strategic sense.